QUIA PHARMA AB — Investor Relations & Filings

QUIA PHARMA AB is a pharmaceutical development company focused on the research, development, and commercialization of medicines. The company's core activity is based on its proprietary and patented drug delivery platform, Uni-Qleaver®. This platform utilizes a unique, releasable pegylation technology designed to improve the properties of drugs by temporarily modifying them. The Uni-Qleaver® technology aims to enhance the therapeutic efficacy and safety profile of pharmaceuticals by extending their duration of action and enabling the release of the active drug in its original, unmodified form. The company applies this platform to develop improved and patentable versions of existing drugs as well as new chemical entities, with a focus on therapeutic areas such as endocrinology and metabolic diseases.